Drug discovery and development is hampered by high failure rates attributed to the reliance on non-human animal models employed during safety and efficacy testing. Here, we try to establish in vitro models of human cardiac and liver tissue. We propose to use a combination of integrated microfluidic systems with electrical and optical detection capability, dynamic controls, and advanced biomaterials to regulate structural organization function of cardiomyocytes and hepatocytes.